Eaton Vance Management’s Ortho Clinical Diagnostics Holdings plc Ordinary Shares OCDX Stock Holding History

Eaton Vance Management’s Portfolio OCDX Stock Details OCDX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-80,653	Closed	-$1.5M	–	1850
2022 Q1	$1.5M	Sell	80,653 -1,401,001	-95%	-$25.2M	﹤0.01%	1265
2021 Q4	$31.7M	Sell	1,481,654 -352,642	-19%	-$6.95M	0.04%	385
2021 Q3	$33.9M	Buy	1,834,296 +1,445,300	+372%	+$29.1M	0.05%	331
2021 Q2	$8.33M	Buy	388,996 +440	+0.1%	+$8.95K	0.01%	648
2021 Q1	$7.5M	Buy	+388,556	New	+$6.85M	0.01%	636

Other funds holding OCDX

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Eaton Vance Management's OCDX Position: Q2 2022 in Review

Eaton Vance Management sold out of Ortho Clinical Diagnostics Holdings plc Ordinary Shares (OCDX) in Q2 2022, closing a stake of 80,653 shares — an estimated $1.5M sold.

Eaton Vance Management first reported a position in OCDX in Q1 2021 and held it in 5 quarters. The position peaked at $33.9M in Q3 2021. 1 fund tracked by Wall St. Rank holds OCDX as of Q2 2022.

Eaton Vance Management reported no remaining Ortho Clinical Diagnostics Holdings plc Ordinary Shares position as of Q2 2022 after selling out during the quarter.
Eaton Vance Management sold 80,653 Ortho Clinical Diagnostics Holdings plc Ordinary Shares shares in Q2 2022, an estimated $1.5M.
Eaton Vance Management first reported a position in Ortho Clinical Diagnostics Holdings plc Ordinary Shares in Q1 2021 and held it in 5 quarters.
Eaton Vance Management's Ortho Clinical Diagnostics Holdings plc Ordinary Shares position peaked at $33.9M in Q3 2021.
1 fund tracked by Wall St. Rank held Ortho Clinical Diagnostics Holdings plc Ordinary Shares as of Q2 2022.

Based on Eaton Vance Management's 13F filing for Q2 2022, filed 15 Aug 2022.